Q BioMed Inc (QBIO) Lifted to “Hold” at Zacks Investment Research
Q BioMed Inc (NASDAQ:QBIO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “
Q BioMed (NASDAQ:QBIO) opened at 3.8885 on Thursday. The stock’s market capitalization is $40.99 million. Q BioMed has a 12-month low of $2.39 and a 12-month high of $12.61. The stock’s 50 day moving average is $4.02 and its 200 day moving average is $4.26.
ILLEGAL ACTIVITY WARNING: “Q BioMed Inc (QBIO) Lifted to “Hold” at Zacks Investment Research” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/08/31/q-biomed-inc-qbio-lifted-to-hold-at-zacks-investment-research.html.
About Q BioMed
Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.
Receive News & Stock Ratings for Q BioMed Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed Inc and related stocks with our FREE daily email newsletter.